Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Rentokil
RTO
|
$510M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$205M |
| 3 |
TFI International
TFII
|
$146M |
| 4 |
Ambev
ABEV
|
$133M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$132M |
Top Sells
| 1 |
Microsoft
MSFT
|
$8.38B |
| 2 |
Apple
AAPL
|
$5.18B |
| 3 |
Mastercard
MA
|
$3.67B |
| 4 |
Alphabet (Google) Class C
GOOG
|
$3.38B |
| 5 |
Amazon
AMZN
|
$3.16B |
Sector Composition
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.68% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Capital One
COF
$142B
| $110M | 0.08% |
1,184,944
-1,136,542
| -49% | -$106M |
|
227
Maximus
MMS
$4.97B
| $110M | 0.08% |
1,501,345
-1,312,343
| -47% | -$96.2M |
|
|
TWNK
228
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $110M | 0.08% |
4,898,377
-7,641,547
| -61% | -$171M |
|
229
Telus
TU
$25.3B
| $109M | 0.08% |
5,650,830
-4,559,412
| -45% | -$88M |
|
230
EnerSys
ENS
$3.89B
| $108M | 0.08% |
1,456,661
-1,475,603
| -50% | -$109M |
|
231
Travere Therapeutics
TVTX
$1.93B
| $107M | 0.08% |
5,091,285
-2,733,685
| -35% | -$57.5M |
|
232
Alight
ALIT
$2B
| $106M | 0.08% |
12,706,476
-8,857,504
| -41% | -$74M |
|
233
ITT
ITT
$13.3B
| $106M | 0.08% |
1,302,212
-1,297,902
| -50% | -$105M |
|
234
Snowflake
SNOW
$75.3B
| $104M | 0.07% |
727,221
-951,409
| -57% | -$137M |
|
235
PagerDuty
PD
$1.54B
| $104M | 0.07% |
3,914,930
-3,994,002
| -50% | -$106M |
|
236
CBRE Group
CBRE
$48.9B
| $103M | 0.07% |
1,339,358
-1,307,604
| -49% | -$101M |
|
237
Royalty Pharma
RPRX
$15.6B
| $103M | 0.07% |
2,600,501
-2,927,661
| -53% | -$116M |
|
238
Dollar Tree
DLTR
$20.6B
| $103M | 0.07% |
725,514
-626,132
| -46% | -$88.6M |
|
239
Frontdoor
FTDR
$4.59B
| $102M | 0.07% |
4,909,392
-5,885,410
| -55% | -$122M |
|
240
Nordson
NDSN
$12.6B
| $97.6M | 0.07% |
410,702
-514,826
| -56% | -$122M |
|
|
ISEE
241
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $97.5M | 0.07% |
4,553,904
-5,673,078
| -55% | -$121M |
|
242
Vistra
VST
$63.7B
| $97.2M | 0.07% |
4,189,078
+1,112,034
| +36% | +$25.8M |
|
243
Healthpeak Properties
DOC
$12.8B
| $97M | 0.07% |
3,872,715
+3,712,383
| +2,315% | +$93M |
|
|
AQUA
244
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $95.7M | 0.07% |
2,416,866
-2,242,438
| -48% | -$88.8M |
|
245
WNS Holdings
WNS
$3.24B
| $94.5M | 0.07% |
1,181,346
-1,352,936
| -53% | -$108M |
|
246
Penumbra
PEN
$11B
| $94M | 0.07% |
422,688
-504,630
| -54% | -$112M |
|
247
The Beauty Health Co
SKIN
$260M
| $93.6M | 0.07% |
10,289,105
-10,915,001
| -51% | -$99.3M |
|
248
Selective Insurance
SIGI
$4.86B
| $93M | 0.07% |
1,049,870
-1,105,404
| -51% | -$97.9M |
|
249
Zurn Elkay Water Solutions
ZWS
$7.71B
| $92.4M | 0.07% |
4,368,285
-4,402,469
| -50% | -$93.1M |
|
|
SUM
250
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $92.3M | 0.07% |
3,252,615
-3,187,210
| -49% | -$90.5M |
|